Skip to main content

Day: July 27, 2020

Athenex, Inc. to Report Second Quarter 2020 Earnings Results on August 6, 2020

BUFFALO, N.Y., July 27, 2020 (GLOBE NEWSWIRE) — Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that it will release second quarter 2020 financial results on Thursday, August 6, 2020, before the market opens, and host a conference call and live audio webcast 8:00am Eastern Time to discuss the financial results and provide a business update.To participate in the call, dial 877-407-0784 (domestic) or 201-689-8560 (international) fifteen minutes before the conference call begins and reference the conference passcode 13706637. The live conference call and replay can also be accessed via audio webcast at the Investor Relations section of the Company’s website, located at...

Continue reading

Lifted Made Launches World’s First Delta-8-THC Nano Drops Under its Urb Finest Flowers Brand

ZION, IL, July 27, 2020 (GLOBE NEWSWIRE) — Lifted Made, a wholly owned subsidiary of publicly traded Acquired Sales Corp. (OTC Pink: AQSP), is excited to announce its launch of the world’s first hemp-derived delta-8-THC nano-particle drops under Lifted Made’s flagship brand Urb Finest Flowers (Instagram @LiftedMade).Urb’s delta-8-THC nano drops are a flavored, water soluble tincture and beverage additive, and are federally legal. The nano drops are sold in a one ounce bottle and contain 333 mg. of delta-8-THC and less than 0.3% delta-9-THC. Currently, the product is available for purchase in three flavors: Go Grape, Let’s Mango, and Orange Dream. The nano drops retail for $34.99/bottle, and are available for purchase online at www.LiftedMade.com and in brick and mortar stores throughout the USA.Delta-8-THC is one of the many cannabinoids...

Continue reading

Ashland announces definitive agreement to sell maleic anhydride business to AOC Materials, LLC for $100 million

WILMINGTON, Del., July 27, 2020 (GLOBE NEWSWIRE) — Ashland Global Holdings Inc. (NYSE: ASH) today announced a definitive agreement to sell the company’s maleic anhydride business and manufacturing facility in Neal, West Virginia to AOC Materials LLC, for $100 million.Maleic anhydride is manufactured industrially on a large scale for applications in coatings and polymers. The maleic anhydride business was previously excluded from the sale of Ashland’s Composites business and the butanediol (BDO) manufacturing facility in Marl, Germany, to INEOS Enterprises. The transaction with AOC is expected to close prior to the end of calendar year 2020, contingent on customary regulatory approvals and standard closing conditions.“Today’s announcement furthers Ashland’s strategic focus to streamline our portfolio and to focus on specialty ingredients...

Continue reading

Descartes and dnata Expand Network for Real-time Air Cargo Tracking

WATERLOO, Ontario, July 27, 2020 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that dnata, one of the world’s largest air services providers, is deploying Descartes Core Bluetooth Low Energy (BLE)™ readers across its global cargo operations to support the tracking of international mail, parcel and cargo shipments.“We rely on best-in-class facilities and state-of-the-art cargo handling technologies to provide over 150 airlines with premium services for approximately 3 million tonnes of cargo annually,” said Guillaume Crozier, Divisional Vice President Operations and Product Development at dnata. “The innovative Descartes solution is expected to help us further improve service efficiency as we move customers’ cargo smoothly from...

Continue reading

Wolverine Worldwide Announces Second Quarter 2020 Conference Call for August 5, 2020

ROCKFORD, Mich., July 27, 2020 (GLOBE NEWSWIRE) — Wolverine World Wide, Inc. (NYSE: WWW) today announced that it expects to report its second quarter 2020 financial results on Wednesday, August 5, 2020, at approximately 6:30 a.m. ET.  Following the press release, the Company will host a conference call at 8:30 a.m. ET to review results and discuss current business trends.The conference call will be broadcast live and accessible under the “Investor Relations” tab at www.wolverineworldwide.com.  A replay of the conference call will be available at the Company’s website for a period of approximately 30 days.ABOUT WOLVERINE WORLDWIDEFounded in 1883 on the belief in the possibility of opportunity, Wolverine World Wide, Inc. (NYSE:WWW) is one of the world’s leading marketers and licensors of branded casual, active lifestyle,...

Continue reading

MediciNova Announces SARS-CoV-2 Vaccine Joint Development with BioComo and Mie University Japan

LA JOLLA, Calif., July 27, 2020 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced an agreement with BioComo (President: Masayuki Fukumura, Mie prefecture, Japan;  http://www.biocomo.jp/) and Mie University (Mie prefecture, Japan) for joint development of a SARS-CoV-2 vaccine using BC-PIV, a human parainfluenza virus type 2 vector developed by BioComo and Tetsuya Nosaka, M.D., Ph.D., professor of the Department of Microbiology and Molecular Genetics, Mie University Graduate School of Medicine.  MediciNova has been granted exclusive worldwide development rights to use BC-PIV for SARS-CoV-2 vaccine development from BioComo and Mie University.BC-PIV, an innovative non-transmissible viral...

Continue reading

Emergent BioSolutions Signs Agreement with AstraZeneca to Expand Manufacturing for COVID-19 Vaccine Candidate

Emergent will provide contract development and manufacturing services beginning in 2020 to produce drug substance at large scale for commercial supplyAgreement is valued at approximately $174 million through 2021 and brings the total AstraZeneca commitment to $261 millionParties may enter into additional commercial manufacturing commitments as the candidate progresses over three years through Emergent’s flexible capacity deployment modelGAITHERSBURG, Md., July 27, 2020 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has signed an agreement to provide contract development and manufacturing (CDMO) services for large-scale commercial drug substance manufacturing for AstraZeneca’s COVID-19 vaccine candidate, AZD1222. The agreement is valued at approximately $174 million through 2021 and follows an $87...

Continue reading

CorVel Leverages Integrated Platform to Provide Liability Management as COVID-19 Claims Rise

IRVINE, Calif., July 27, 2020 (GLOBE NEWSWIRE) — CorVel Corporation, a national provider of risk management solutions, is leveraging its experience and technology to provide clients with liability management services and  monitor emerging legislation as claims related to COVID-19 increase.As the global pandemic continues to impact the country, liability claims are proliferating. Employers are facing claims such as alleged negligence to provide adequate personal protective equipment (PPE) or social distancing, and failure to have contingency plans in place to protect employees. CorVel’s national liability division is providing insight and guidance to clients regarding COVID-19 claim reporting and best-practice handling, along with 24/7 catastrophic assistance for third-party claimants.Legislation and state orders focusing on compensability...

Continue reading

AMREP Reports Fiscal 2020 Results

PLYMOUTH MEETING, Pennsylvania, July 27, 2020 (GLOBE NEWSWIRE) — AMREP Corporation (NYSE: AXR) today reported a net loss of $5,903,000, or $0.73 per share, for its 2020 fiscal year ended April 30, 2020 compared to net income of $1,527,000, or $0.19 per share, for the prior year.Results for 2020 included $8,600,000 of non-cash charges comprised of: (1) a non-cash pre-tax pension settlement charge of $2,929,000 due to the payment of lump sum payouts of pension benefits to 309 former employees and (2) net non-cash pre-tax impairment charges on other assets of $5,046,000 in connection with certain deemed consideration from the sale of the Company’s fulfillment services business. Results for 2019 reflected a net loss from continuing operations of $2,465,000 and net income from discontinued operations of $3,992,000. Discontinued operations...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.